Ken Fisher's AZN Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 10.8 M shares of AstraZeneca PLC (AZN) worth $1.99 B, representing 0.68% of the portfolio. First purchased in 2015-Q3, this long-term strategic position has been held for 42 quarters.
Based on 13F filings since 2013, Ken Fisher has maintained a long-term strategic position in AZN, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2025, adding 4.6 M shares. Largest reduction occurred in Q3 2022, reducing 6.22 M shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's AstraZeneca PLC (AZN) Holding Value Over Time
Track share changes against reported price movement
Quarterly AstraZeneca PLC (AZN) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +219,354 | Add 2.07% | 10.8 M | $183.86 |
| Q3 2025 | +233,372 | Add 2.26% | 10.58 M | $153.44 |
| Q2 2025 | +265,260 | Add 2.63% | 10.35 M | $139.76 |
| Q1 2025 | +4.6 M | Add 83.99% | 10.08 M | $147.00 |
| Q4 2024 | +239,846 | Add 4.58% | 5.48 M | $131.04 |
| Q3 2024 | +262,088 | Add 5.26% | 5.24 M | $155.82 |
| Q2 2024 | +151,286 | Add 3.13% | 4.98 M | $155.98 |
| Q1 2024 | +138,610 | Add 2.96% | 4.83 M | $135.50 |
| Q4 2023 | +102,592 | Add 2.24% | 4.69 M | $134.70 |
| Q3 2023 | +119,908 | Add 2.69% | 4.59 M | $135.44 |
| Q2 2023 | +90,564 | Add 2.07% | 4.47 M | $143.14 |
| Q1 2023 | +23,822 | Add 0.55% | 4.38 M | $138.82 |
| Q4 2022 | -120,250 | Reduce 2.69% | 4.35 M | $135.60 |
| Q3 2022 | -6.22 M | Reduce 58.19% | 4.47 M | $109.68 |
| Q2 2022 | +272,444 | Add 2.61% | 10.69 M | $132.14 |
| Q1 2022 | +366,479 | Add 3.64% | 10.42 M | $132.68 |
| Q4 2021 | +260,129 | Add 2.66% | 10.05 M | $116.50 |
| Q3 2021 | +379,568 | Add 4.03% | 9.79 M | $120.12 |
| Q2 2021 | +220,902 | Add 2.40% | 9.42 M | $119.80 |
| Q1 2021 | +268,957 | Add 3.01% | 9.19 M | $99.44 |
| Q4 2020 | +254,047 | Add 2.93% | 8.93 M | $99.98 |
| Q3 2020 | +207,868 | Add 2.46% | 8.67 M | $109.60 |
| Q2 2020 | +185,185 | Add 2.24% | 8.46 M | $105.78 |
| Q1 2020 | +92,933 | Add 1.14% | 8.28 M | $89.32 |
| Q4 2019 | +54,374 | Add 0.67% | 8.19 M | $99.72 |
| Q3 2019 | +178,834 | Add 2.25% | 8.13 M | $89.14 |
| Q2 2019 | +264,848 | Add 3.45% | 7.95 M | $82.56 |
| Q1 2019 | +204,678 | Add 2.74% | 7.69 M | $80.86 |
| Q4 2018 | +724,258 | Add 10.72% | 7.48 M | $75.96 |
| Q3 2018 | +218,392 | Add 3.34% | 6.76 M | $79.14 |
| Q2 2018 | +267,890 | Add 4.27% | 6.54 M | $70.22 |
| Q1 2018 | +313,414 | Add 5.26% | 6.27 M | $69.94 |
| Q4 2017 | +157,880 | Add 2.72% | 5.96 M | $69.40 |
| Q3 2017 | +259,858 | Add 4.69% | 5.8 M | $67.76 |
| Q2 2017 | +4.58 M | Add 476.85% | 5.54 M | $68.18 |
| Q1 2017 | -14,954 | Reduce 1.53% | 960,546 | $62.28 |
| Q4 2016 | -13,292 | Reduce 1.34% | 975,500 | $54.64 |
| Q3 2016 | +819,302 | Add 483.39% | 988,792 | $65.72 |
| Q2 2016 | +52,786 | Add 45.23% | 169,490 | $59.94 |
| Q1 2016 | +5,901 | Add 5.33% | 116,704 | $59.42 |
| Q4 2015 | +96,829 | Add 692.92% | 110,803 | $67.90 |
| Q3 2015 | +13,974 | New Buy | 13,974 | $63.62 |
Ken Fisher's AstraZeneca PLC Investment FAQs
Ken Fisher first purchased AstraZeneca PLC (AZN) in Q3 2015, acquiring 13,974 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held AstraZeneca PLC (AZN) for 42 quarters since Q3 2015.
Ken Fisher's largest addition to AstraZeneca PLC (AZN) was in Q1 2025, adding 10,082,730 shares worth $1.48 B.
According to the latest 13F filing for Q4 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 10,800,716 shares of AstraZeneca PLC (AZN), valued at approximately $1.99 B.
As of the Q4 2025 filing, AstraZeneca PLC (AZN) represents approximately 0.68% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in AstraZeneca PLC (AZN) was 10,800,716 shares, as reported at the end of Q4 2025.